Clinical evaluation of serum tissue polypeptide specific antigen in patients with thyroid carcinoma

Thyroid

Volumn 9, Issue 9, 1999, Pages 921-925

  Suzuki, Shinichi ^a   Furukawa, Hiroshi ^a   Tsuchiya, Atsuo ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; GOITER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THYROID ADENOMA; THYROID MEDULLARY CARCINOMA;

EID: 0032837124     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1999.9.921     Document Type: Article

References (19)

1. Pacini F, Martino E, Bambini G, Aghini-Lonbardi F, Taddei D, Lari R, Pinchera A, Baschieri L 1985 Humoral markers for thyroid carcinoma. Cancer Detect Prevent 8:17-22.
2. Martino E, Bambini G, Aghini-Lombardi F, Motz E, Pacini F, Lari R, Baschieri L, Pinchera A 1984 Serum tissue polypeptide antigen (TPA) in thyroid cancer. J Endocrinol Invest 7:249-252.
3. Luthgens M, Schkegel G (eds) 1989 Clinical use of the Tumor Marker System, CEA-TPA. Tumor Diagnostik Verlag, Leonberg, p 25.
4. Severlini G, Gentilini L and Tirelli C 1991 Diagnostic evaluation of alanine aminopeptidase as serum marker for detecting cancer. Cancer Biochem Biophysics 12:199-204.
5. Björklund B and Björklund V 1987 Biochemische und morphologische Grundlagen von TPA; Fortschritte in Richtung auf einem allgemeinen Marker fur aktive Tumoren durch monoklonale Kartierung. In: Luthgens M, Schlegel G (eds) Tumor-Marker System (CEA-TPA. Tumor Diagnostik Verlag, Loenberg, pp 14-29.
6. Pujol JL, Cooper EH, Grenier J, Purves DA, Lehmann M, Ray P, Aouta MD, Bashir M, Godard P, Michel FB 1994 Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer. Eur J Cancer 30A:1768-1774.
7. Willsher PC, Beaver J, Blarney RW, Robertson JF 1995 Serum tissue polypeptide specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEA. Anticancer Res 15:1609-1611.
8. Tarle M 1993 Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer. Anticancer Res 13:769-777.
9. Pasanen PA, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Alhava E 1994 Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma. Tumour Biol 15:52-60.
10. Shabana A, Onsrud M 1994 Tissue polypeptide-specific antigen and CA 125 as serum tumor markers in ovarian carcinoma. Tumour Biol 15:361-367.
11. Gitsch G, Kainz Cu, Joura E, Frohlich B, Bieglmayr C, Tatra G 1992 Squamous cell carcinoma antigen, tumor associated trypsin inhibitor and tissue polypeptide specific antigen in follow up of stage III cervical cancer. Anticancer Res 12: 1247-1249.
12. Bonfrer JMJ, Groeneveld EM, Korse CM, van Dalen A, Oomen LCJM, Ivanyi D 1994 Monoclonal antibody M3 used in tissue polypeptide-specific antigen assay for the quantification of tissue polypeptide antigen recognizes keratin 18. Tumour Biol 15:210-222.
13. Rydlander L, Ziegler E, Bergman T, Schoberl E, Steiner G, Bergman A.-C, Zetterberg A, Marberger M, Bjorklund P, Skern T, Einarsson R, Jornvall H 1996 Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18. Eur J Biochem 291: 309-319.
14. Metz CE, Godenough DJ, Rossman K 1973 Evaluation of receiver operating characteristics curve data in terms of information theory with applications to radiology. Radiology 109:297-304.
15. Wells SA Jr, Haagensen DE, Linehan WM 1978 The detection of elevated plasma level of carcinoembryonic antigen in patients with suspected or established medullary thyroid carcinoma. Cancer 42:1498-1503.
16. Spencer CA 1996 Thyrogobulin. In: Braverman LE, Utiger RD, (eds) Werner and Ingbar's The Thyroid. 7th edition. Lippincott-Raven Publishers, Philadelphia, pp 406-415.
17. Björklund B, Björklund V 1957 Antigenicity of pooled human malignant and normal tissues by cyto-immunological technique. Int Arch Allergy 10:153-184.
18. Halim A-B, El-Ahmady O, El-Sokkary F, Motavi T 1993 How can you choose a biological marker panel for gynecological cancer? Cancer J 6:201-207.
19. Suzuki S, Kiman K, Furukawa H, Tsuchiya A, Abe R 1996 Clinicopathological study of follicular thyroid carcinoma. [English abstract] Endocr Surg 13:217-223.